Evidence map›Paper›PMID 28380037›Full record

ArticlePloS one2017

Comparison of the current AJCC-TNM numeric-based with a new anatomical location-based lymph node staging system for gastric cancer: A western experience.

Gennaro Galizia, Eva Lieto, Annamaria Auricchio, Francesca Cardella, Andrea Mabilia, Anna Diana, Paolo Castellano, Ferdinando De Vita, Michele Orditura

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.5field-weighted citation impact, top 11% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 19 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Prognostic impact of anatomical extent of metastatic lymph node on gastric cancer: a propensity score matching study.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2021
    Article
  6. Article
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Gennaro GaliziaDivision of Surgical Oncology, Department of Surgical Sciences, University of Campania 'Luigi Vanvitelli', School of Medicine, Naples, Italy.ORCID http://orcid.org/0000-0002-6897-0391
Eva LietoDivision of Surgical Oncology, Department of Surgical Sciences, University of Campania 'Luigi Vanvitelli', School of Medicine, Naples, Italy.
Annamaria AuricchioDivision of Surgical Oncology, Department of Surgical Sciences, University of Campania 'Luigi Vanvitelli', School of Medicine, Naples, Italy.
Francesca CardellaDivision of Surgical Oncology, Department of Surgical Sciences, University of Campania 'Luigi Vanvitelli', School of Medicine, Naples, Italy.
Andrea MabiliaDivision of Surgical Oncology, Department of Surgical Sciences, University of Campania 'Luigi Vanvitelli', School of Medicine, Naples, Italy.
Anna DianaDivision of Medical Oncology, "F. Magrassi" Department of Clinical and Experimental Medicine and Surgery, University of Campania 'Luigi Vanvitelli', School of Medicine, Naples, Italy.
Paolo CastellanoDivision of Surgical Oncology, Department of Surgical Sciences, University of Campania 'Luigi Vanvitelli', School of Medicine, Naples, Italy.
Ferdinando De VitaDivision of Medical Oncology, "F. Magrassi" Department of Clinical and Experimental Medicine and Surgery, University of Campania 'Luigi Vanvitelli', School of Medicine, Naples, Italy.
Michele OrdituraDivision of Medical Oncology, "F. Magrassi" Department of Clinical and Experimental Medicine and Surgery, University of Campania 'Luigi Vanvitelli', School of Medicine, Naples, Italy.
University of Campania "Luigi Vanvitelli" · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundIn gastric cancer, the current AJCC numeric-based lymph node staging does not provide information on the anatomical extent of the disease and lymphadenectomy. A new anatomical location-based node staging, proposed by Choi, has shown better prognostic performance, thus soliciting Western world validation. STUDY

designData from 284 gastric cancers undergoing radical surgery at the Second University of Naples from 2000 to 2014 were reviewed. The lymph nodes were reclassified into three groups (lesser and greater curvature, and extraperigastric nodes); presence of any metastatic lymph node in a given group was considered positive, prompting a new N and TNM stage classification. Receiver-operating-characteristic (ROC) curves for censored survival data and bootstrap methods were used to compare the capability of the two models to predict tumor recurrence.

resultsMore than one third of node positive patients were reclassified into different N and TNM stages by the new system. Compared to the current staging system, the new classification significantly correlated with tumor recurrence rates and displayed improved indices of prognostic performance, such as the Bayesian information criterion and the Harrell C-index. Higher values at survival ROC analysis demonstrated a significantly better stratification of patients by the new system, mostly in the early phase of the follow-up, with a worse prognosis in more advanced new N stages, despite the same current N stage.

conclusionsThis study suggests that the anatomical location-based classification of lymph node metastasis may be an important tool for gastric cancer prognosis and should be considered for future revision of the TNM staging system.

Indexed as

AgedBayes TheoremFemaleGastrectomyHumansLymphatic MetastasisLymph Node ExcisionLymph NodesMaleMiddle AgedNeoplasm Recurrence, LocalNeoplasm StagingPrognosisROC CurveStomachStomach Neoplasms

Identifiers

PMID28380037
PMCPMC5381862
OpenAlexW2604119236

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.